GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (MIC:REGN-RM) » Definitions » Cyclically Adjusted PB Ratio

Regeneron Pharmaceuticals (MIC:REGN-RM) Cyclically Adjusted PB Ratio : (As of Jul. 18, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Regeneron Pharmaceuticals Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Regeneron Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.52 9.95 8.39 8.03 5.26

Regeneron Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.24 8.54 8.13 5.26 4.44

Competitive Comparison of Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Regeneron Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Regeneron Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=22436.364/134.9266*134.9266
=22,436.364

Current CPI (Mar. 2025) = 134.9266.

Regeneron Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 1,792.606 100.684 2,402.273
201509 2,082.028 100.392 2,798.254
201512 2,557.537 99.792 3,457.976
201603 2,427.003 100.470 3,259.341
201606 2,470.909 101.688 3,278.568
201609 2,686.350 101.861 3,558.379
201612 2,532.575 101.863 3,354.631
201703 2,563.598 102.862 3,362.728
201706 3,062.324 103.349 3,997.993
201709 3,261.785 104.136 4,226.235
201712 3,286.496 104.011 4,263.350
201803 3,486.525 105.290 4,467.919
201806 4,182.733 106.317 5,308.304
201809 4,765.335 106.507 6,036.901
201812 5,585.179 105.998 7,109.473
201903 5,594.327 107.251 7,037.949
201906 5,603.615 108.070 6,996.208
201909 6,036.895 108.329 7,519.083
201912 6,231.951 108.420 7,755.536
202003 8,607.248 108.902 10,664.194
202006 5,977.360 108.767 7,414.957
202009 7,498.885 109.815 9,213.677
202012 7,682.279 109.897 9,431.974
202103 8,524.645 111.754 10,292.224
202106 10,419.013 114.631 12,263.673
202109 11,622.702 115.734 13,550.103
202112 12,769.001 117.630 14,646.648
202203 19,090.248 121.301 21,234.633
202206 11,901.814 125.017 12,845.244
202209 11,881.391 125.227 12,801.729
202212 12,655.445 125.222 13,636.253
202303 16,114.966 127.348 17,074.010
202306 17,899.621 128.729 18,761.434
202309 22,068.103 129.860 22,929.197
202312 21,418.349 129.419 22,329.767
202403 22,414.033 131.776 22,949.890
202406 23,141.121 132.554 23,555.362
202409 24,134.872 133.029 24,479.164
202412 28,813.748 133.157 29,196.649
202503 22,436.364 134.927 22,436.364

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Regeneron Pharmaceuticals  (MIC:REGN-RM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Regeneron Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Regeneron Pharmaceuticals Business Description

Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Regeneron Pharmaceuticals Headlines

No Headlines